BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Medtech Medical Diagnostic

Fujitsu Japan And JMDC Partner To Accelerate Data Driven Healthcare In Japan

Fujitsu Japan Limited and JMDC Inc. announced the commencement of a collaboration aimed at advancing medical care and contributing to the establishment of ...

February 11, 2026 | News

Innovate UK Funds AI Platform To Predict Hospital Infections Up To Seven Days Earlier

Funding supports the co-design and roll-out of MEMORI, a Class IIb CE-certified SaMD platform, tailored to local clinical teams and systems ME...

February 11, 2026 | News

Neurophet Secures Third FDA Clearance For AI Driven Alzheimer’s Imaging Platform

Following AQUA and SCALE PET, the latest FDA clearance reinforces Neurophet's leadership in AI-based Alzheimer's disease imaging analysis Advanced ...

February 09, 2026 | News

China Approves Promega OncoMate MSI Companion Diagnostic For KEYTRUDA Therapy

The National Medical Products Administration (NMPA) has approved the OncoMate® Microsatellite Instability (MSI) Detection Kit as a Class III in vi...

February 06, 2026 | News

Innovations In Magnetic Resonance Imaging Introduced By United Imaging

Tomorrow's technology. Artificial intelligence and the uCS platform The key to the innovations introduced by United Imaging is the combination of advanced...

February 05, 2026 | News

ZEISS Secures NMPA Approval For ARTEVO 750 And ARTEVO 850 Ophthalmic Surgical Microscopes In China

ZEISS ARTEVO 750 and ZEISS ARTEVO 850 surgical microscopes provide ophthalmic surgeons in China with end-to-end workflow integration to improve efficiency,...

February 04, 2026 | News

Ascletis Pharma Reports Positive Phase III Safety Results For Denifanstat In Moderate To Severe Acne

Denifanstat (ASC40), a once-daily oral fatty acid synthase (FASN) inhibitor, demonstrated favorable safety and tolerability in a Phase III open-label ...

February 03, 2026 | News

China Approves World First cAMP Biased GLP One Receptor Agonist For Type Two Diabetes

Sciwind Biosciences Co., Ltd. ("Sciwind"), a biopharmaceutical company focused on the discovery and development of innovative therapies for metabolic disea...

February 02, 2026 | News

China Originated Innovation Is Rising. Global Expectations Are Rising Even Faster.

The momentum is real—and so is the level of scrutiny. As more programs move beyond regional boundaries, expectations from global biopharma companies ...

February 02, 2026 | News | By Anil Kane, executive director, global head of technical and scientific affairs, Thermo Fisher Scientific

Beckman Coulter Life Sciences And Automata Form Strategic Partnership To Advance AI Ready Lab Automation

Beckman Coulter Life Sciences and Automata announced a strategic partnership that integrates Beckman Coulter Life Sciences liquid handling, genomic and cel...

February 02, 2026 | News

Skyhawk Therapeutics Reports Positive Nine Month Interim Data For SKY 0515 In Huntington’s Disease

Nine-month findings show mean improvement in Composite Unified Huntington's Disease Rating Scale from baseline of +0.64 points, compared to natural hi...

January 29, 2026 | News

Japan Tissue Engineering Co Secures National Insurance Reimbursement For JACC In Knee Osteoarthritis

-Japan Tissue Engineering Co., Ltd.（J-TEC） announced that JACC, its autologous cultured cartilage product, has been granted approval by Japan&rsqu...

January 28, 2026 | News

BioMed X Launches EU Backed AI Precision Medicine Project With Barbados To Address Early Diabetic Kidney Disease

The new project, supported by the European Union’s PharmaNext Programme, focuses on population-specific molecular profiling and AI-driven precision m...

January 28, 2026 | News

Merz Therapeutics Submits XEOMIN For Paediatric Spasticity Indication Across Europe

Merz Therapeutics, a leading player in neurology-focused specialty pharma, announced that it has completed the regulatory submission for XEOMIN®&...

January 27, 2026 | News

Stay Connected